Depreciation in USD of Enveric Biosciences, Inc. from 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Enveric Biosciences, Inc. quarterly/annual Depreciation history and change rate from 2013 to Q3 2025.
  • Enveric Biosciences, Inc. Depreciation for the quarter ending September 30, 2025 was $40.4K, a 5.3% decline year-over-year.
  • Enveric Biosciences, Inc. Depreciation for the twelve months ending September 30, 2025 was $159K, a 6.69% decline year-over-year.
  • Enveric Biosciences, Inc. annual Depreciation for 2024 was $169K, a 3.7% decline from 2023.
  • Enveric Biosciences, Inc. annual Depreciation for 2023 was $175K, a 10.1% increase from 2022.
  • Enveric Biosciences, Inc. annual Depreciation for 2022 was $159K, a 1096% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Enveric Biosciences, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $159K $40.4K -$2.26K -5.3% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 $162K $40K -$2.61K -6.13% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $164K $38.8K -$4.38K -10.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $169K $40.3K -$2.19K -5.16% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-28
Q3 2024 $171K $42.6K -$1.48K -3.35% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 $172K $42.6K -$1.74K -3.93% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 $174K $43.2K -$1.08K -2.43% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q4 2023 $175K $42.5K -$1.82K -4.1% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-28
Q3 2023 $177K $44.1K -$353 -0.79% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $177K $44.3K +$1.02K +2.35% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $176K $44.3K +$17.2K +63.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $159K $44.3K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $44.5K +$42.2K +1885% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $43.3K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $27.1K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 $2.24K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q1 2016 $112K +$103K +1238% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-16
Q1 2015 $8.34K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16

Enveric Biosciences, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $169K -$6.49K -3.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-28
2023 $175K +$16.1K +10.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-28
2022 $159K +$146K +1096% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $13.3K Jan 1, 2021 Dec 31, 2021 10-K/A 2023-06-09
2016 $1.36M +$1.19M +719% Jan 1, 2016 Dec 31, 2016 10-K/A 2017-04-04
2015 $166K +$133K +398% Jan 1, 2015 Dec 31, 2015 10-K/A 2017-04-04
2014 $33.4K +$33.3K +28669% Apr 1, 2014 Mar 31, 2015 10-KT 2016-03-15
2013 $116 Apr 1, 2013 Mar 31, 2014 10-KT 2016-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.